Fanye Meng
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 6
- Histone Deacetylase Inhibitors Research 2
- Fibroblast Growth Factor Research 2
- Kruppel-like factors research 1
- Oncology 7
- Peptidase Inhibition and Analysis 5
- Co-authors
- Jian Jin (8 shared papers)H. Ümit Kanıskan (6 shared papers)He Chen (3 shared papers)Yudao Shen (3 shared papers)Yi Liu (1 shared paper)Wenyi Wei (1 shared paper)Jing Liu (1 shared paper)Richard Fellows (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Journal of the American Chemical Society (2 papers)European Journal of Medicinal Chemistry (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Electronics (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Fanye Meng
18 papers receiving 791 citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 136
- Oncology 263
- Developmental Neuroscience 36
- Molecular Biology 579
- Management Science and Operations Research 45
Countries citing papers authored by Fanye Meng
This map shows the geographic impact of Fanye Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanye Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanye Meng more than expected).
Fields of papers citing papers by Fanye Meng
This network shows the impact of papers produced by Fanye Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanye Meng. The network helps show where Fanye Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanye Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Selective Target Degradation by Folate-Caged PROTACs Hit paper breakdown → | 2021 | 219 |
| 2 | 2020 | 144 | |
| 3 | 2021 | 96 | |
| 4 | 2010 | 67 | |
| 5 | 2014 | 67 | |
| 6 | 2021 | 42 | |
| 7 | 2023 | 40 | |
| 8 | 2022 | 39 | |
| 9 | 2020 | 29 | |
| 10 | 2023 | 16 | |
| 11 | 2016 | 16 | |
| 12 | 2024 | 9 | |
| 13 | 2023 | 8 | |
| 14 | 2025 | 8 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 |
About Fanye Meng
Fanye Meng is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Biomedical Engineering, having authored 19 papers that have together received 810 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (6 papers), Peptidase Inhibition and Analysis (5 papers), Histone Deacetylase Inhibitors Research (2 papers), Fibroblast Growth Factor Research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Muscle activation and electromyography studies (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Hematology (136 citations), Oncology (263 citations), Developmental Neuroscience (36 citations), Molecular Biology (579 citations) and Management Science and Operations Research (45 citations). Fanye Meng has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jian Jin, H. Ümit Kanıskan, He Chen, Yudao Shen, Yi Liu, Wenyi Wei, Jing Liu, Richard Fellows, Junying Liu and Kwang‐Su Park. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of the American Chemical Society, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Electronics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.